Cargando…

Synergistic effects of combined immunotherapy strategies in a model of multifocal hepatocellular carcinoma

Immune checkpoint-inhibitor combinations are the best therapeutic option for advanced hepatocellular carcinoma (HCC) patients, but improvements in efficacy are needed to improve response rates. We develop a multifocal HCC model to test immunotherapies by introducing c-myc using hydrodynamic gene tra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ochoa, Maria Carmen, Sanchez-Gregorio, Sandra, de Andrea, Carlos E., Garasa, Saray, Alvarez, Maite, Olivera, Irene, Glez-Vaz, Javier, Luri-Rey, Carlos, Etxeberria, Iñaki, Cirella, Assunta, Azpilikueta, Arantza, Berraondo, Pedro, Argemi, Josepmaria, Sangro, Bruno, Teijeira, Alvaro, Melero, Ignacio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140615/ https://www.ncbi.nlm.nih.gov/pubmed/37040772 http://dx.doi.org/10.1016/j.xcrm.2023.101009

Ejemplares similares

Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists
por: Cirella, Assunta, et al.
Publicado: (2023)

Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic
por: Alvarez, Maite, et al.
Publicado: (2023)

mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy
por: Olivera, Irene, et al.
Publicado: (2023)

Intratumoral co‐injection of NK cells and NKG2A‐neutralizing monoclonal antibodies
por: Melero, Ignacio, et al.
Publicado: (2023)

Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
por: Glez-Vaz, Javier, et al.
Publicado: (2022)

Repurposing the yellow fever vaccine for intratumoral immunotherapy
por: Aznar, Maria Angela, et al.
Publicado: (2019)

New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis
por: Etxeberria, Iñaki, et al.
Publicado: (2020)

Human CD8 T cells are susceptible to TNF-mediated activation-induced cell death
por: Otano, Itziar, et al.
Publicado: (2020)

Cellular cytotoxicity is a form of immunogenic cell death
por: Minute, Luna, et al.
Publicado: (2020)

Three-dimensional colon cancer organoids model the response to CEA-CD3 T-cell engagers
por: Teijeira, Alvaro, et al.
Publicado: (2022)

CD137 (4-1BB) costimulation of CD8(+) T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation
por: Otano, Itziar, et al.
Publicado: (2021)

Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8(+) T cells eradicates peritoneal metastases in mouse models
por: Di Trani, Claudia Augusta, et al.
Publicado: (2022)

ICAM-1-LFA-1 Dependent CD8+ T-Lymphocyte Aggregation in Tumor Tissue Prevents Recirculation to Draining Lymph Nodes
por: Yanguas, Alba, et al.
Publicado: (2018)

In situ detection of vaccine mRNA in the cytoplasm of hepatocytes during COVID-19 vaccine-related hepatitis
por: Martin-Navarro, Loreto, et al.
Publicado: (2023)

Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications
por: Bella, Ángela, et al.
Publicado: (2021)

Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosis
por: Bella, Ángela, et al.
Publicado: (2023)

Immunotherapeutic effects of intratumoral nanoplexed poly I:C
por: Aznar, M. Angela, et al.
Publicado: (2019)

Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy
por: Alvarez, Maite, et al.
Publicado: (2021)

Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis
por: Bella, Ángela, et al.
Publicado: (2022)

Cytokines in clinical cancer immunotherapy
por: Berraondo, Pedro, et al.
Publicado: (2018)

Identifying New Epigenetic Drivers of Liver Fibrosis
por: Argemi, Josepmaria, et al.
Publicado: (2018)

504. Case SEries: Nasal Antimicrobial Photodisinfection (APDT) as Treatment Protocol for Asymptomatic and Early Stage COVID-19 Patients
por: Kolenda, Jack, et al.
Publicado: (2021)

High-density lipoproteins delivering interleukin-15
por: Ochoa, Maria C., et al.
Publicado: (2013)

Therapeutic activity of a combination of immunostimulatory monoclonal antibodies (anti-B7-H1, CD137 and OX40) on a c-myc-driven spontaneous transgenic model of hepatocellular carcinoma
por: Morales-Kastresana, Aizea, et al.
Publicado: (2013)

Impact of prophylactic TNF blockade in the dual PD-1 and CTLA-4 immunotherapy efficacy and toxicity
por: Alvarez, Maite, et al.
Publicado: (2019)

JIND: joint integration and discrimination for automated single-cell annotation
por: Goyal, Mohit, et al.
Publicado: (2022)

CRMP2 as a Candidate Target to Interfere with Lung Cancer Cell Migration
por: Morales, Xabier, et al.
Publicado: (2021)

Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure
por: Di Trani, Claudia Augusta, et al.
Publicado: (2023)

Innate Functions of Immunoglobulin M Lessen Liver Gene Transfer with Helper-Dependent Adenovirus
por: Unzu, Carmen, et al.
Publicado: (2014)

CD137 (4-1BB) Signalosome: Complexity Is a Matter of TRAFs
por: Zapata, Juan M., et al.
Publicado: (2018)

Serum Acylcarnitines Associated with High Short-Term Mortality in Patients with Alcoholic Hepatitis
por: Gao, Bei, et al.
Publicado: (2021)

Essential complicity of perforin-granzyme and FAS-L mechanisms to achieve tumor rejection following treatment with anti-CD137 mAb
por: Morales-Kastresana, Aizea, et al.
Publicado: (2013)

4-1BB (CD137) in anticancer chimeras
por: Melero, Ignacio, et al.
Publicado: (2020)

Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood
por: Rodríguez‐Pena, Alejandro, et al.
Publicado: (2022)

Experience with health care integration in Bidasoa integrated health organisation: development of the continuity of care unit/Experiencia de integración en la Organización Sanitaria Integrada Bidasoa: desarrollo de la Unidad de Continuidad Asistencial
por: Zabalegui, Iñaki Berraondo
Publicado: (2012)

β3 integrin expression is required for invadopodia-mediated ECM degradation in lung carcinoma cells
por: Peláez, Rafael, et al.
Publicado: (2017)

Initial Afferent Lymphatic Vessels Controlling Outbound Leukocyte Traffic from Skin to Lymph Nodes
por: Teijeira, Alvaro, et al.
Publicado: (2013)

Identifying key multifunctional components shared by critical cancer and normal liver pathways via SparseGMM
por: Bakr, Shaimaa, et al.
Publicado: (2023)

Reduced Serum Sphingolipids Constitute a Molecular Signature of Malnutrition in Hospitalized Patients With Decompensated Cirrhosis
por: Rachakonda, Vikrant, et al.
Publicado: (2019)

Editorial: ‘Inter-identities' in Life, Mind, and Society
por: Etxeberria, Arantza, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h1is9v51fmpbtha2hdfboh9s05